Literature DB >> 34436535

Has the Current Oncology Value Paradigm Forgotten Patients' Time?: Too Little of a Good Thing.

Adam Fundytus1,2, Vinay Prasad3, Christopher M Booth1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34436535     DOI： 10.1001/jamaoncol.2021.3600

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy.

Authors:  Ian Alberts; Robin Schepers; Konstantinos Zeimpekis; Hasan Sari; Axel Rominger; Ali Afshar-Oromieh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-22       Impact factor: 10.057

2.  Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022.

Authors:  Idine Mousavi; Timothée Olivier; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Cancer treatments should benefit patients: a common-sense revolution in oncology.

Authors:  Bishal Gyawali; Christopher M Booth
Journal:  Nat Med       Date:  2022-04       Impact factor: 87.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.